Structural and mechanistic underpinnings of the differential drug sensitivity of EGFR mutations in non-small cell lung cancer

MJ Eck, CH Yun - Biochimica et Biophysica Acta (BBA)-Proteins and …, 2010 - Elsevier
drugs found their target against mutant forms of the EGFR … exquisite sensitivity of a subset
of these lung cancer mutants to … activation of the EGFR kinase by these mutants, and compare …

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations

K Suda, T Mitsudomi - Cells, 2021 - mdpi.com
… mechanisms of drug tolerance of EGFR-mutated lung cancers … of an optimal treatment for
EGFR-mutated lung cancer will … highest sensitivities to EGFR TKIs, the vast majority of EGFR-…

Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations

E Avizienyte, RA Ward, AP Garner - Biochemical Journal, 2008 - portlandpress.com
… To address whether ErbB2 can modulate the sensitivity of EGFR to inhibitors we also …
stably expressing ErbB2 with the EGFR mutation library and selected for drug-resistant growth in …

Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitors

M Juchum, M Günther, SA Laufer - Drug Resistance Updates, 2015 - Elsevier
… are known to render the development of novel targeted drugs … by EGFR and only a
subpopulation has an activating mutation (eg L858R), making them sensitive to first generation …

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

JH Starrett, AA Guernet, ME Cuomo, KE Poels… - Cancer research, 2020 - AACR
… To determine whether the observed effects of the TKIs on the different osimertinib-resistant
mutations in vitro correlated with in vivo drug sensitivity, we treated mice with EGFR L858R …

Treatment strategies for non-small cell lung cancer harboring common and uncommon EGFR mutations: drug sensitivity based on exon classification, and structure …

R Kitadai, Y Okuma - Cancers, 2022 - mdpi.com
… NSCLC have revealed resistance mechanisms and drug sensitivity. In this review, we … EGFR
mutations. We will also focus on EGFR-TKI sensitivity in patients harboring EGFR mutations

Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations

S Ikemura, H Yasuda, S Matsumoto… - Proceedings of the …, 2019 - National Acad Sciences
EGFR mutation diversity and the efficacy of EGFR-TKIs for a subset of mutants prompted
us to apply our in silico drug sensitivitysensitivity of two representative rare EGFR mutants, …

Presence of the minor EGFR T790M mutation is associated with drug-sensitive EGFR mutations in lung adenocarcinoma patients

S Hashida, J Soh, S Toyooka, T Tanaka… - Oncology …, 2014 - spandidos-publications.com
… to treatment with EGFR-tyrosine kinase inhibitors (EGFR-TKIs) (… with drug-sensitive EGFR
mutations such as EGFR exon 19 … mutation initially show satisfactory responsiveness to EGFR-…

Uncommon epidermal growth factor receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and …

E Massarelli, FM Johnson, HS Erickson, II Wistuba… - Lung Cancer, 2013 - Elsevier
… T854A was identified in one patient with a drug-sensitive EGFR L858R-mutant lung
adenocarcinoma after long-term treatment with TKI [53]. Growth inhibition assays using transfected …

Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity

K Suda, T Mitsudomi - Archives of toxicology, 2015 - Springer
EGFR mutations are highly responsive to EGFR-TKIs, and the type of mutation correlates with
the sensitivity … Membrane transporters or drug efflux pumps can increase the sensitivity or …